DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,485 | -55.9% | 6 | -97.5% | 0.00% | -100.0% |
| Q2 2023 | $3,370 | +532.3% | 240 | -4.8% | 0.01% | -43.8% |
| Q1 2023 | $533 | -71.6% | 252 | -4.9% | 0.02% | +60.0% |
| Q4 2022 | $1,875 | -99.7% | 265 | -74.3% | 0.01% | -44.4% |
| Q3 2022 | $546,000 | +1.7% | 1,032 | +1.6% | 0.02% | +5.9% |
| Q2 2022 | $537,000 | -13.4% | 1,016 | -13.3% | 0.02% | 0.0% |
| Q1 2022 | $620,000 | -91.6% | 1,172 | -86.8% | 0.02% | -89.8% |
| Q4 2021 | $7,390,000 | +2291.6% | 8,901 | +21609.8% | 0.17% | +15.2% |
| Q3 2021 | $309,000 | +13.2% | 41 | 0.0% | 0.14% | +48.0% |
| Q2 2021 | $273,000 | -95.0% | 41 | -2.4% | 0.10% | -12.5% |
| Q1 2021 | $5,487,000 | +27335.0% | 42 | -53.8% | 0.11% | +522.2% |
| Q4 2020 | $20,000 | -99.9% | 91 | -79.3% | 0.02% | -78.3% |
| Q1 2020 | $26,943,000 | +10987.7% | 440 | -46.9% | 0.08% | -50.3% |
| Q4 2019 | $243,000 | +35.8% | 828 | -33.3% | 0.17% | +8.4% |
| Q3 2019 | $179,000 | -27.2% | 1,241 | -28.0% | 0.15% | -23.8% |
| Q2 2019 | $246,000 | +40.6% | 1,723 | +30.0% | 0.20% | +42.3% |
| Q1 2019 | $175,000 | +66.7% | 1,325 | +22.2% | 0.14% | +29.1% |
| Q3 2018 | $105,000 | -11.0% | 1,084 | -7.5% | 0.11% | -0.9% |
| Q2 2018 | $118,000 | +110.7% | 1,172 | +108.9% | 0.11% | +94.7% |
| Q1 2018 | $56,000 | – | 561 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |